|
INTREPId (INTermediate Risk Erection PreservatIon Trial): A randomized trial of radiation therapy and darolutamide for prostate cancer. |
|
|
|
|
|
Employment - Best Doctors, Inc |
|
Consulting or Advisory Role - Foundation Medicine; Gerson Lehrman Group; Guidepoint Global; Leap Therapeutics; Pfizer |
Travel, Accommodations, Expenses - Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
|
|
Research Funding - Apex Neuro |
|
|
Employment - Decipher Biosciences; GenomeDx |
Leadership - Decipher Biosciences; GenomeDx |
Stock and Other Ownership Interests - Decipher Biosciences; GenomeDx |
Patents, Royalties, Other Intellectual Property - CANCER DIAGNOSTICS USING BIOMARKERS 20140066323 |
Travel, Accommodations, Expenses - GenomeDx |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Augmenix; Volatilyx (I) |
Consulting or Advisory Role - Astellas Pharma; Augmenix; Augmenix; Bayer; Biogen (I); Blue Earth Diagnostics; Boston Scientific; Coda; Dendreon; Ferring; GenomeDx; GigaGen (I); Janssen Oncology; Medivation; Nanobiotix |
Research Funding - Astellas Pharma; Janssen; Nanobiotix; Wako Diagnostics (I) |
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I) |
Travel, Accommodations, Expenses - Ferring |